EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported second-quarter net income of $111.3 million.

On a per-share basis, the Exton, Pennsylvania-based company said it had profit of $1.51. Earnings, adjusted for amortization costs, were $1.52 per share.

The results missed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.77 per share.

The medical device company posted revenue of $702.1 million in the period, which also missed Street forecasts. Four analysts surveyed by Zacks expected $737.7 million.

West Pharmaceutical expects full-year earnings in the range of $6.35 to $6.65 per share, with revenue in the range of $2.87 billion to $2.9 billion.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on WST at https://www.zacks.com/ap/WST